Recursion Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of RXRX for the last quarter is 13.79 M USD, and it's 26.66% higher compared to the previous quarter. The net income of Q1 24 is -91.37 M USD.